A Comparison of Mortality From Sepsis in Brazil and England:The Impact of Heterogeneity in General and Sepsis-Specific Patient Characteristics by Ranzani, Otavio T. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1097/CCM.0000000000003438
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Ranzani, O. T., Shankar-Hari, M., Harrison, D. A., Rabello, L. S., Salluh, J. I. F., Rowan, K. M., & Soares, M.
(2018). A Comparison of Mortality From Sepsis in Brazil and England: The Impact of Heterogeneity in General
and Sepsis-Specific Patient Characteristics. Critical Care Medicine, Online First.
https://doi.org/10.1097/CCM.0000000000003438
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
 1 
A comparison of mortality from sepsis in Brazil and England: 
the impact of heterogeneity in general and sepsis-specific 
patient characteristics 
 
 
 
Otavio T. Ranzani1,2$ MD, Manu Shankar-Hari1,3,4$ MSc MD PhD, David A. Harrison1 PhD, Lígia S. 
Rabello5 MD MSc PhD†, Jorge I. F. Salluh5 MD PhD, Kathryn M. Rowan1 PhD*, Marcio Soares5 MD PhD* 
 
1 Intensive Care National Audit & Research Centre (ICNARC), London, UK;  
2 Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, 
Universidade de Sao Paulo, SP, Brazil;   
3 Guy’s and St Thomas’ Hospital NHS Foundation Trust, London, UK;  
4 School of Immunology & Microbial Sciences, Kings College London, London, UK; 
5 Department of Critical Care and Graduate Program in Translational Medicine, D’Or Institute for 
Research and Education - IDOR, Rio De Janeiro, Brazil 
 
$ Equal contributors  
*Joint senior authors 
 
† In memoriam 
 
Corresponding author: 
Otavio T. Ranzani, MD 
Pulmonary Division, Heart Institute (InCor), Medical School, University of São Paulo 
Laboratório de Pneumologia, 2º andar, sala 2144 
Av. Dr. Arnaldo, 455 -, Postcode 01246903 
São Paulo, São Paulo - Brazil 
email: otavioranzani@usp.br 
Tel: +55 11 3061 7361; Fax: +55 11 3061 2492 
 
 
Declaration of interests The authors declare no conflicts of interest. 
Manuscript word count: 3,132 
 
Copyright form disclosure: Dr. Soares disclosed that he is founder and equity 
shareholder at Epimed Solutions. The remaining authors have disclosed that they do 
not have any potential conflicts of interest. 
 2 
Abstract 
 
Objective: To test whether differences in both general and sepsis-specific patient 
characteristics explain the observed differences in sepsis mortality between countries, 
using two national critical care (ICU) databases. 
 
Design: Cohort study. 
 
Setting: We analyzed 62 and 164 ICUs in Brazil and England, respectively. 
 
Patients: 22,426 adult ICU admissions from January 2013 to December 2013. 
 
Interventions: None. 
 
Measurements and Main Results: After harmonizing relevant variables, we merged 
the first ICU episode of adult medical admissions from Brazil (ORCHESTRA study) and 
England (ICNARC Case Mix Programme). Sepsis-3 definition was used and the primary 
outcome was hospital mortality. We used multilevel logistic regression models to 
evaluate the impact of country (Brazil versus England) on mortality, after adjustment for 
general (age, sex, comorbidities, functional status, admission source, time to admission) 
and sepsis-specific (site of infection, organ dysfunction (OD) type and number) patient 
characteristics. Of medical ICU admissions, 13.2% (4,505/34,150) in Brazil and 30.7% 
(17,921/58,316) in England met the sepsis definition. The Brazil cohort was older, had 
greater prevalence of severe comorbidities and dependency compared with England. 
Respiratory was the most common infection site in both countries. The most common 
OD was cardiovascular in Brazil (41.2%) and respiratory in England (85.8%). Crude 
hospital mortality was similar (Brazil 41.4% versus England 39.3%, OR=1.12 [0.98-
1.30]). After adjusting for general patient characteristics, there was an important change 
in the point-estimate of the odds ratio (OR=0.88 [0.75-1.02]). However, after adjusting 
for sepsis-specific patient characteristics, the direction of effect reversed again with 
Brazil having higher risk-adjusted mortality (OR=1.22 [1.05-1.43]). 
 
Conclusions Patients with sepsis admitted to ICUs in Brazil and England have 
important differences in general and sepsis-specific characteristics, from source of 
admission to organ dysfunctions. We show that comparing crude mortality from sepsis 
patients admitted to the ICU between countries, as currently performed, is not reliable 
and that the adjustment for both general and sepsis-specific patient characteristics is 
essential for valid international comparisons of mortality amongst sepsis patients 
admitted to critical care units. 
 
Keywords:  sepsis; intensive care; epidemiology; outcomes; international; 
heterogeneity 
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Introduction 
Sepsis is defined as life-threatening organ dysfunction due to dysregulated host 
response to infection(1, 2). Recently, the World Health Organization (WHO) recognized 
sepsis as a global health priority, highlighting the importance of accurate international 
benchmarking to inform regional health policy(3). The key drivers for this WHO 
resolution include a high extrapolated global sepsis burden of 15 to 20 million cases per 
annum(4, 5) and the 26% average hospital mortality with sepsis-related critical 
illness(5).  There are several global initiatives to address the high mortality from 
sepsis(6, 7), but little consensus on how best to do international comparisons.  
 
The crude hospital mortality from sepsis varies significantly between countries in 
prevalence studies(5, 8-10). This variation in mortality has been linked to differences in 
critical care (ICU) provision(11, 12), case definition(13), sepsis incidence(9), economic 
region(8) and to differences in guideline compliance(10, 14-16). In this scenario, Brazil 
and England have important differences, such as higher critical care bed availability per 
population in Brazil (13 per 100,000 inhabitants) compared with England (3.5–7.4 per 
100,000 inhabitants)(17). These between countries differences highlight the need for 
standardized benchmarking to compare sepsis mortality, because crude mortality 
comparisons would be not accurate(5, 17).  
 
At the patient level, both general patients characteristics (such as age, sex, presence of 
comorbidities) and sepsis-specific characteristics (such as site of infection and number 
and type of organ dysfunction) are important determinants of mortality in septic 
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patients(17-19). However, lack of readily available calibrated risk prediction models and 
agreed risk adjustment methods that are easy to implement across countries, precludes 
risk-adjusted mortality comparisons between countries. Added to this is the 
heterogeneity observed among patients with sepsis, which presents a further challenge 
in designing risk-adjusted mortality comparisons(17, 20). Together with incorporating 
new biomarkers and deriving phenotypes(20), another approach uses main 
determinants of the syndrome sepsis, such as site of infection and associated organ 
dysfunction, to account for sepsis heterogeneity(17).   
 
It is feasible to do comparisons between countries using national level databases(21) 
and it is also feasible to collect general and sepsis-specific patient characteristics 
accurately across countries(8, 9). In this context, we hypothesized that a sequential 
adjustment for general and for sepsis-specific patient characteristics would illustrate the 
limitations of comparing crude mortality rates. To test this hypothesis, we harmonized 
two ICU databases from Brazil and England, with the first ICU episode for adult medical 
admissions with sepsis in 2013. We report crude, stratified and adjusted hospital 
mortality comparisons between the two countries, incrementally adjusting for general, 
and then for sepsis-specific, patient characteristics. 
 
Methods 
Data sources and funding 
We used two national ICU databases to identify sepsis cohorts from Brazil and England 
admitted in 2013. The ORCHESTRA (ORganizational CHaractEeriSTics in cRitcal cAre) 
 5 
study was a multicenter retrospective cohort study of critical care organization in 11 
Brazilian states coordinated by the Department of Critical Care at the D’Or Institute for 
Research and Education. The data was collected by dedicated and trained staff through 
the Epimed Monitor System® (Epimed Solutions®, Rio de Janeiro, Brazil)(22). During 
selection of ICUs for ORCHESTRA, six ICUs with >10% of missing data on core 
variables (age, ICU admission diagnosis, ICU and hospital length of stay (LOS) and 
hospital mortality) and two ICUs with <12 months of patient data were excluded, 
resulting in 78 ICUs at 51 hospitals (46 private and 5 public) with available data. For this 
study, we excluded 16 specialized ICUs (e.g., cardiothoracic, neurological, etc) resulting 
in 62 general ICUs in Brazil sepsis cohort. The Intensive Care National Audit & 
Research Centre Case Mix Programme database (ICNARC-CMPD) is the national 
clinical audit for adult general ICUs in England. This database includes data from 164 
ICUs in England. The data are collected by dedicated and trained staff to a defined 
dataset specification including the hierarchical ICNARC Coding Method(23). All 164 
ICUs in England had ≤10% of missing data on core variables and contributed ≥12 
months of patient data. Both these high-quality ICU databases collect 
sociodemographic, comorbidity, physiological and outcomes data for consecutive ICU 
admissions to precise rules and definitions. Both databases undergo extensive data 
validation; the details of which have been reported previously(22, 23). Local Ethics 
Committee at the Instituto D’Or de Pesquisa (Parecer: 334.835) and the Brazilian 
National Ethics Committee (CAAE: 19687113.8.1001.5249) approved the ORCHESTRA 
study. Support for the collection and use of the ICNARC-CPMD data has been obtained 
under Section 251 of the National Health Service Act 2006 (approval number: PIAG 2–
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10(f)/2005).  
Harmonization of datasets 
We used a flexible harmonization method(24). First, we defined, a priori, the target 
variables necessary to test our hypothesis. The data collection forms and data 
dictionaries from ORCHESTRA and the ICNARC-CMPD datasets were then assessed 
and consensus achieved on the target variables that could be reliably determined and 
mapped in both datasets. Both datasets were separately prepared, quality checked and 
anonymized using the same algorithm to generate the harmonized variables and a 
merged dataset that included country as a categorical variable. Harmonization steps 
were conducted before any statistical analysis. 
Patients and variables in the harmonized dataset 
We included the first ICU admission for adult (≥16 years) medical (non-surgical) patients 
with sepsis to adult general ICUs between 1 January and 31 December 2013. We 
excluded patients transferred in from other hospitals, and patients admitted to 
specialized ICUs (e.g. cardiothoracic, neurological/neurosurgical and stand-alone high 
dependency units).  
General patient characteristics included age, sex, comorbidities, functional status, 
source of admission and time from hospital to ICU admission. Comorbidities were 
based on the APACHE II definitions in the ICNARC-CMPD and the Charlson 
comorbidity index in the ORCHESTRA study. We classified patients’ functional status in 
two categories: independent and partially or fully dependent (eTable-1). Sepsis-specific 
patient characteristics included site of infection, number and type of organ 
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dysfunction(17). Sepsis was defined as infection and ≥2 points in any individual domain 
of the Sequential Organ Failure Assessment (SOFA) score using data from the first 24h 
of ICU admission (eTable-2). Site of infection was determined at ICU admission and 
coded using hierarchical codes in both datasets (eTable-3). 
Statistical analysis 
The primary exposure was country (Brazil or England) and the primary outcome was 
hospital mortality. The analysis plan was finalized prior to any analysis.  
We used three sequential random effects, multilevel logistic regression models to 
evaluate the impact of country on hospital mortality. First, we fitted a baseline model 
with the country (Brazil/England) as a fixed effect and ICU as random effect (model-1). 
Second, to model-1, we added all general patient characteristics (age, sex, 
comorbidities, functional status, source of ICU admission, and time from hospital 
admission to ICU admission) (model-2). Third, to model-2, we added sepsis-specific 
patient characteristics (site of infection and organ dysfunctions representing acute 
illness severity) (model-3). We ran the same three sequential models in two sensitivity 
analyses: 1) in the subpopulation of patients without chronic comorbidities, to evaluate 
the potential impact of SOFA definition in patients with chronic organ dysfunction; 2) 
handling the immunosuppression category as originally entered in the database, to 
evaluate the potential different prognostic impact of each immunosuppressed category. 
Because of the multicollinearity between type and number of organ dysfunctions, we 
assessed the impact of organ dysfunction in two different ways: first, in model-3A we 
adjusted only for the types of organ dysfunctions and their first order interactions and 
second, in model-3B, we adjusted only for the number of organ dysfunctions. Age and 
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time from hospital admission to ICU admission were fitted using restricted cubic splines 
to deal with non-linear associations in all models. The potential for effect modification of 
the effect of country on outcome was explored by adding interaction terms between 
country and the following pre-specified covariates in model-3: source of admission 
(emergency department versus other), time from hospital admission to ICU admission 
(<1 day, 1-2 days, 3-7 days, ≥8 days) and site of infection, type of organ dysfunction 
(model-3A) or number of organ dysfunctions (model-3B). Finally, we explored the 
interaction between country effect and baseline predicted risk of hospital mortality using 
the linear predictor of fixed effects from model-3.  
We used Wald tests for all hypothesis testing. As the amount of missing data at 
individual patient level for all non-core variables was expected to be low (<5%), the 
primary analysis was complete case analysis. Continuous variables are presented as 
mean (SD) for those that were not skewed and median [IQR] for those skewed. 
Categorical variables are presented as counts and percentages. All analyses were 
performed using Stata/SE Version 13.0 (StataCorp LP, College Station, TX). 
 
Results 
Patient selection 
Over the study period, amongst the 34,150 and 58,316 adult medical ICU admissions, 
10,167 (29.8%) and 19,491 (33.4%) patients had infection as the main reason for 
admission to ICUs in Brazil and England, respectively. From these cohorts, we included 
4,505/10,167 (44.3%) patients with sepsis from Brazil and 17,921/19,491 (92.0%) from 
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England who had organ failure and met the sepsis criteria (eFigure1). There were 
22,061 (98.4%) sepsis patients for complete case analysis. 
 
General characteristics 
Sepsis admissions to ICUs in Brazil were older, with greater prevalence of comorbidities 
and impaired functional status. The most common source of admission to ICU in Brazil 
was the emergency department (ED) (N=3,250; 72.1%) and the general ward 
(N=11,023; 61.5%) in England. Sepsis patients admitted to ICUs in Brazil spent a longer 
pre-ICU admission period either in the ED or on the ward compared with sepsis 
admissions to ICUs in England (Table1).  
 
Sepsis specific characteristics 
The most common infection source amongst ICU admissions with sepsis was 
respiratory for both countries. Genitourinary as an infection source was 3.5 times more 
common in Brazil and gastrointestinal was twice as common in England. The 
percentage of sepsis admissions with single organ dysfunction was higher in Brazil 
(54.9% versus 32.8%), whilst those with two, three, four and five organ dysfunctions 
were higher in England. Cardiovascular was the most common organ dysfunction in 
Brazil (41.2%) and respiratory was the most common organ dysfunction in England 
(85.8%) (Table1, eTable3). 
 
Mortality 
The crude hospital mortality for all medical ICU patients and for infected ICU patients 
was lower for Brazil compared to England (18.6% vs. 30.6% for medical; 27.1% vs. 
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37.2% for infected patients). In contrast, the crude hospital mortality for ICU sepsis 
admissions was comparable between Brazil (41.4%) and England (39.3%). However, 
when stratified by source of admission, site of infection, type, number and combinations 
of organ dysfunction, sepsis admissions to ICUs in Brazil had higher crude mortality 
(Table2, Figure1). Overall, ICU and hospital LOS were similar between countries, 
however, non-survivors had greater ICU and hospital LOS in Brazil compared with 
England (eTable3). 
 
Impact of sequential risk factor adjustment with multilevel logistic regression 
models 
There was no statistically significant difference in the crude mortality between the two 
countries (crude OR 1.12 [0.98-1.30] for Brazil versus England, p=0.11, model-1). After 
adjusting for general patient characteristics, there was a change in the point estimate of 
the OR, which highlighted that the general patient characteristics confounded the 
sepsis-mortality relationship (adjusted OR 0.88 [0.75-1.02] for Brazil versus England, 
p=0.09, model-2). When we adjusted for general and for sepsis-specific patient 
characteristics, the point estimate reversed, with sepsis admissions in Brazil having 
significantly greater odds of hospital death compared with England (model-3A: adjusted 
OR 1.22 [1.05-1.43], p=0.01; model-3B: adjusted OR 1.40 [1.22-1.62], p<0.01; Table3). 
The two sensitivity analyses showed similar phenomena in the reversal of the point-
estimate of the association when adjusting for general and sepsis-specific 
characteristics (eTable5). 
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Effect modifiers of the country effect on mortality 
The country effect also varied with time from hospitalization to ICU admission, site of 
infection, type and number of organ dysfunctions strata, implying effect modification of 
these variables in the sepsis-mortality relationship (Figure2 and eFigure2; eTable6; e-
Table7). Brazil had worse outcomes for those with very low- and very-high predicted 
risk of hospital death, which implies interaction between country effect and baseline 
predicted risk of death (Figure3, eFigure2, eTable8; eTable9). 
 
Discussion 
We report the first study testing the impact of general and sepsis-specific patient 
characteristics, whilst accounting for country effect, in the sepsis-mortality relationship, 
using harmonized raw patient-level clinical data from two high quality ICU databases. 
Brazil had a greater prevalence of patients with sepsis-specific characteristics 
associated with lower risk of death such as genitourinary infection and single organ 
dysfunction and a greater prevalence of patients with general patient characteristics 
associated with higher risk of death such as older age, comorbidities and impaired 
functional status. Although the overall crude hospital mortality was similar between 
Brazil and England, there were major differences in the stratified hospital mortality. 
Brazil had a significantly higher adjusted risk of death from sepsis when general and 
sepsis-specific patient characteristics were accounted for.  
 
The framework for international comparisons of sepsis cohorts presented in this study 
addresses the challenges highlighted with crude comparisons(17) and provides novel 
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data towards 2017 WHO agenda(3, 25) - on the need for better evaluation tools for 
global sepsis epidemiology. As illustrated in our two national cohorts, sepsis-specific 
patient characteristics such as site of infection, the number and types of organ 
dysfunctions are likely to vary between health care systems/countries. Therefore, it is 
expected that general prognostic models such as APACHE II, where sepsis might be a 
single category weighted by a single coefficient, are not enough to capture the impact of 
the variation of sepsis-specific patient characteristics on mortality. Our model accounted 
for those important variables, used commonly collected variables and used two 
accessible modelling strategies to enhance the adjustments: (1) for sepsis-specific 
patient characteristics, by including a first order interaction between organ dysfunctions 
and (2) for unmeasured variability at the health unit level, by including random 
intercepts for each unit(17). Nevertheless, it is possible that a more complex model, 
allowing for other acute physiological derangements, could improve the adjustments 
between cohorts. 
 
The strong impact of sepsis-specific characteristics on the country-associated hospital 
mortality also must be highlighted. Indeed, sepsis from neurological infections and those 
patients with increasing number of organ dysfunctions seem to drive the change on the 
direction of the OR after adjusting for general and sepsis-specific characteristics. This 
should be further evaluated, but it might represent differences in health practices within 
each country, such as clinical suspicion and organ support indications. Moreover, it 
might be informative for international benchmarking, highlighting room for improvement 
in specific sepsis diagnosis and care areas. 
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Our study has strengths. We harmonized data variables between two representative 
national ICU databases(22, 23), using similar definitions(24), over the same period and 
explicitly tested for country effect after adjusting for key confounders(26). We developed 
our statistical analysis plans blinded to country level outcome data. The harmonization 
of data variables and application of hierarchical multilevel regression analysis, allowing 
for random effects, is methodologically robust for testing our research question(27). We 
used previously reported sepsis-specific patient characteristics and current knowledge 
from sepsis epidemiology for adjustment and comparison between cohorts(17). 
Importantly, the proposed adjustment based on target variables for general and for 
sepsis-specific patient characteristics are feasible and reproducible, both fundamental 
features for international comparisons, and for informed benchmarking.  
 
Our study has several limitations. Although neither ICU database was set up for 
exploring sepsis epidemiology, they are appropriate to inform how adjustment for both 
general and sepsis-specific patient characteristics could improve upon the crude 
mortality comparisons often reported. There is no “gold-standard” for international 
comparisons of sepsis epidemiology(17). However, we illustrate that outcome variability 
is partially related to differences in type of sepsis patients cared between Brazil and 
England. Thus, such comparisons are feasible, and our hypothesis driven risk-
adjustment proposal provides a valid starting point to generate between country 
estimates for external benchmarking. We used our previously published feasible risk 
adjustment methods(17), including variables commonly measured in the ICUs that are 
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well-known risk factors for sepsis mortality, and illustrate the impact of sequential 
adjustment for general and for sepsis-specific patient characteristics. Nevertheless, we 
made minor adaptations in the comorbidities and SOFA definitions to harmonize both 
datasets. We believe these adaptations might have introduced some degree of non-
differential misclassification, according to the flexible harmonization approach(24). We 
could not measure access to the health system, the ICU capacity strain during the 
period, do-not resuscitate practices, refused admissions to critical care and discharge 
practices. The finding that lower- and higher-risk patients have worse outcomes in the 
Brazilian cohort might reflect differences in these factors. Restricted by available data in 
the ICU databases, we could not generalize our findings to sepsis patients treated 
outside the ICU, however we applied a standardized sepsis definition in patients 
admitted to general ICUs, strengthening our internal validity. We applied a modified 
version of the SOFA score, missing the liver domain. However, the expected incidence 
of liver dysfunction is low in adult general ICUs and commonly occurs simultaneously 
with other organ dysfunctions, such that we anticipate that we may have missed only 
very small differences between the cohorts. Finally, we compared two countries for this 
case-study and explored the country variable as a fixed effect. If more countries were to 
be evaluated, it may be advisable to consider a random effects approach.  
 
Our study informs future research. First, our study highlights an approach for 
international comparisons of sepsis mortality that requires replication. Our approach is 
very similar to the cancer literature, where international differences in stage-specific 
cancer survival between countries could be explained by differences in general patient 
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characteristics such as comorbidities and cancer-specific patient characteristics such as 
cancer stage(28, 29). Second, the process of care improvement strategies for sepsis is 
likely to vary by country(14) which requires formal testing. For example, the impact of 
pre-ICU time: we observed that patients in Brazil were commonly referred direct to ICU, 
whilst higher proportions of patients in England were transferred to general wards prior 
to ICU admission. Additionally, the country effect on sepsis hospital mortality varied with 
time from hospitalization to ICU admission. This could also imply differences in the 
magnitude of strain(30, 31) operating on the general wards and in the ICUs between 
countries. The treatment these patients received pre-ICU admission is also of 
paramount importance, because of the importance of early treatment for sepsis 
patients(32). We observed that, despite similar proportions of patients with infection at 
ICU admission, the proportion of admissions with sepsis was lower in Brazil compared 
with England, potentially explained by the lower admission threshold of private ICUs 
contributing to the ORCHESTRA database. Third, international harmonization of ICU 
clinical trials and large global adaptive platform trials are being considered(33). Our 
study highlights the need to have stratification by country to account for the differences 
in crude mortality and to explore biological differences in treatment response in sepsis 
populations between countries.  
 
Conclusion 
Our study highlights that crude mortality comparison of sepsis patients admitted to 
critical care units is of limited value in understanding reasons for differences in outcome 
between countries. Both general and sepsis-specific patient characteristics influence 
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mortality of sepsis patients admitted to the ICU and are distributed differently between 
cohorts from the two countries. We provide a template for studies attempting 
international benchmarking of ICU sepsis mortality. 
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Figures 
Figure Legends 
 
 
Figure 1 – Observed hospital mortality stratified by country, site of infection 
(Figure 1-A) and number of organ dysfunctions (Figure 1-B) 
 
Figure 2 – Effect modification of country effect on hospital mortality and by pre-
specified subgroups and by deciles of the predicted risk from the Model 3-A 
 
Model 3-A was adjusted for general (age, sex, cardiovascular, respiratory, renal, hepatic 
comorbidities, immunocompromised, functional status and, admission source and time 
from hospitalization to ICU admission) and sepsis-specific characteristics (site of 
infection and type of organ dysfunction and first-order interaction between each organ 
dysfunction system) 
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Table 1. General and sepsis-specific patient characteristics of patients with sepsis 
 
General patient characteristics England (n=17,921) Brazil (n=4,505) 
Age, mean (SD) 64.3 (16) 68.9 (19) 
Sex (male) 9992 (55.8%) 2327 (51.7%) 
Predicted risk of hospital death1, mean (SD) ICNARC model 38.8% (29) 
SAPS 3 model 
40.0% (24) 
Comorbidities4   
Severe cardiovascular disease 340 (1.9%) 42 (0.9%) 
Severe respiratory disease 676 (3.8%) 433 (9.6%) 
Renal disease (chronic renal failure under RRT) 433 (2.4%) 328 (7.3%) 
Chronic liver disease 509 (2.8%) 109 (2.4%) 
Immunocompromised 1704 (9.5%) 693 (15.4%) 
Haematological malignancy 855 (4.8%) 229 (5.1%) 
AIDS 29 (0.2%) 118 (2.6%) 
Metastatic disease (solid neoplasia) 440 (2.5%) 259 (5.8%) 
Steroid use 535 (3.0%) 164 (3.6%) 
Functional status   
Independent 11922 (66.8%)3 2247 (53.2%)2 
Partially or fully dependent 5915 (33.2%) 1978 (46.8%) 
Source of admission   
Emergency department 5912 (33.0%) 3250 (72.1%) 
Ward 11023 (61.5%) 990 (22.0%) 
High dependency unit 824 (4.6%) 129 (2.9%) 
Other 162 (0.9%) 136 (3.0%) 
Time from hospital admission to ICU admission, days 
mean (SD) / median (p25-p75)   3.4 (7) / 1 (0-3) 3.7 (10) / 0 (0-2) 
Among those from emergency department  0.3 (2) / 0 [0-0] 1.1 (5) / 0 [0-0] 
Among those from ward 4.8 (8) / 2 [1-5] 10.6 (14) / 5 [2-13] 
Sepsis-specific patient characteristics   
Site of infection   
Respiratory 11078 (61.8%) 2285 (50.7%) 
Genitourinary 865 (4.8%) 748 (16.6%) 
Gastrointestinal 2304 (12.9%) 296 (6.6%) 
Muscoloskeletal/Dermatological 739 (4.1%) 251 (5.6%) 
Neurological 445 (2.5%) 43 (0.9%) 
Cardiovascular 351 (2.0%) 111 (2.5%) 
Unknown 2139 (11.9%) 771 (17.1%) 
Type of organ dysfunctions within first 24h   
Respiratory 15371 (85.8%) 1768 (39.3%) 
Cardiovascular 6137 (34.2%) 1857 (41.2%) 
Renal 7324 (40.9%) 1496 (33.2%) 
Hematological 3609 (20.1%) 872 (19.4%) 
Neurological 6358 (35.5%) 1647 (36.6%) 
Organ support during critical care stay   
Advanced respiratory support 9230 (51.5%) 1995 (44.3%) 
Advanced cardiovascular support 6137 (34.2%) 1866 (41.4%) 
Advanced renal support 3439 (19.2%) 647 (14.4%) 
 
1The risk of death was estimated based on the ICNARC model, 2015 recalibration for England cohort and based on SAPS3 
model from Brazil cohort, using standard equations.  
2 n=280 and 3n= 84 missing values;  
4please refer to eTable-2 for definitions of comorbid conditions used in the study;  
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Table 2. Hospital mortality stratified by country, by structure and by sepsis-specific patient 
characteristics  
Outcomes England (n=17,921) Brazil (n=4,505) 
ICU mortality 5496 (30.7%) 1431 (31.8%) 
Hospital mortality 7045 (39.3%) 1867 (41.4%) 
By source of admission   
Emergency department 2054/5912 (34.7%) 1152/3250 (35.5%) 
Ward 4571/11023 (41.5%) 589/990 (59.5%) 
HDU 360/824 (43.7%) 73/129 (56.6%) 
Other 60/162 (37.0%) 53/136 (39.0%) 
By functional status   
Independent 4173/11922 (35.0%) 780/2247 (34.7%) 
Partially or fully dependent 2831/5915 (47.9%) 967/1978 (48.9%) 
By Site of infection   
Respiratory 4480/11078 (40.4%) 1008/2285 (44.1%) 
Genitourinary 192/865 (22.2%) 214/748 (28.6%) 
Gastrointestinal 885/2304 (38.4%) 132/296 (44.6%) 
Musculoskeletal/Dermatological 260/739 (35.2%) 87/251 (34.7%) 
Neurological 77/445 (17.3%) 18/43 (41.9%) 
Cardiovascular 150/351 (42.7%) 48/111 (43.2%) 
Unknown 1001/2139 (46.8%) 360/771 (46.7%) 
By number of organ dysfunctions within first 24h   
1 1385/5881 (23.6%) 642/2474 (26.0%) 
2 2090/5852 (35.7%) 616/1205 (51.1%) 
3 2015/3935 (51.2%) 400/577 (69.3%) 
4 1250/1856 (67.4%) 184/220 (83.6%) 
5 305/397 (76.8%) 25/29 (86.2%) 
Type of organ dysfunction within first 24h   
Respiratory 6211/15371 (40.4%) 995/1768 (56.3%) 
Cardiovascular 3418/6137 (55.7%) 1075/1857 (57.9%) 
Renal 3646/7324 (49.8%) 669/1496 (44.7%) 
Hematological 1666/3609 (46.2%) 366/872 (42.0%) 
Neurological 3194/6358 (50.2%) 830/1647 (50.4%) 
By type of organ dysfunction alone and in 
combinations1   
Respiratory (only) 970/4317 (22.5%) 124/449 (27.6%) 
Cardiovascular (only) 72/185 (38.9%) 142/419 (33.9%) 
Renal (only) 201/749 (26.8%) 120/598 (20.1%) 
Hematological (only) 51/281 (18.2%) 62/356 (17.4%) 
Neurological (only) 91/349 (26.1%) 194/652 (29.8%) 
Respiratory + Cardiovascular 497/1089 (45.6%) 178/294 (60.5%) 
Respiratory + Neurological 546/1686 (32.4%) 105/200 (52.5%) 
Cardiovascular + Renal 87/217 (40.1%) 71/157 (45.2%) 
Respiratory + Cardiovascular + Renal 567/989 (57.3%) 112/153 (73.2%) 
Respiratory + Cardiovascular + Neurological 479/998 (48.0%) 144/210 (68.6%) 
Respiratory + Cardiovascular + Renal + Neurological 710/991 (71.6%) 104/123 (84.6%) 
Organ support during ICU stay   
Advanced respiratory support 4482/9230 (48.6%) 1366/1995 (68.5%) 
Advanced cardiovascular support 3418/6137 (55.7%) 1136/1866 (60.9%) 
Advanced renal support 1897/3439 (55.2%) 428/647 (66.2%) 
1Organ dysfunctions combinations with at least 100 occurrences in both datasets (Totals 11,851 (66%) 
patients from England and 3,611 (80%) patients from Brazil) 
ICU – intensive care unit; HDU – high dependency unit.  
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Table 3. Adjusted multilevel logistic regression models for the country effect (Brazil versus England) on sepsis hospital mortality 
 
Model Exposure OR (95% CI) P value AUROC Brier score 
Model 1 – Baseline model Brazil/England 1.12 (0.98-1.30) 0.105 0.608 (0.600-0.615) 0.2303 
Model 2 – Adjusted for general characteristics1 Brazil/England 0.88 (0.75-1.02) 0.089 0.712 (0.705-0.719) 0.2082 
Model 3A – Adjusted for general + sepsis-specific characteristics 
(site of infection and type of organ dysfunction)2 Brazil/England 1.22 (1.05-1.43) 0.010 0.784 (0.778-0.790) 0.1838 
Model 3B – Adjusted for general + sepsis-specific characteristics 
(site of infection and number of organ dysfunction)3 Brazil/England 1.40 (1.22-1.62) <0.001 0.777 (0.771-0.783) 0.1864 
 
1 Adjusted for age (restricted cubic spline), sex, cardiovascular, respiratory, renal, hepatic comorbidities, immunocompromised, functional status 
and, admission source and time from hospitalization to ICU admission (restricted cubic spline) 
2 Adjusted for characteristics in model 2 + site of infection and type of organ dysfunction and first-order interaction between each organ 
dysfunction system 
3 Adjusted for characteristics in model 2 + site of infection and number of organ dysfunctions (Number of organ failures entered as factors)  
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eTable1: Comorbidity definitions for Brazil (Charlson comorbidities) and England (APACHE II 
definitions) (green stands for full match / salmon for partial match / red for poor match) 
 
Comorbidities Brazil England 
Severe cardiovascular disease NYHA IV NYHA IV 
Severe respiratory disease Severe COPD 
Severe respiratory disease (Chronic 
restrictive, obstructive or vascular 
disease with severe exercise 
restriction); Respiratory dependency 
Renal disease (chronic renal failure 
under RRT) Chronic dialysis Chronic dialysis 
Chronic liver disease Cirrhosis Child AB; Child C; Hepatic failure 
Bx-proven cirrhosis and documented 
hypertension; 
GI bleeding due to portal 
hypertension; 
Hepatic 
failure/encephalopathy/coma 
Immunocompromised   
Haematological malignancy Haematological malignancy Haematological malignancy 
AIDS AIDS AIDS 
Metastatic disease (solid neoplasia) Metastatic disease Metastatic disease 
Steroid use Steroid use Steroid use 
   
Functional status   
Independent* 
Fully active, able to carry on 
all activities without 
restriction 
No assistance to carry out activities 
of daily living 
Partially or fully dependent* 
From restriction in physically 
strenuous activity but 
ambulatory and able to carry 
out work of a light or 
sedentary to completely 
disabled; not carrying on any 
selfcare; totally confined to 
bed or chair 
Partial or total assistance to carry 
out activities of daily living 
 
NYHA IV – New York Heart Association (NYHA) Functional Classification 
COPD: Chronic Obstructive Pulmonary Disease 
AIDS – Acquired immune deficiency syndrome 
 
 
* Both definitions have full match for the “independent” category, thus the complement of it “non-
independent” (partially of fully dependent) have also full match. This variable was entered as a binary 
variable (independent x non-independent). 
eTable2: Modified SOFA score definitions: calculated with the worst values within first 24h of 
admission (green stands for full match / salmon for partial match / red for poor match) 
  Brazil England 
 Points Definition by: PaO2/FiO2 (mmHg) Definition by: PaO2/FiO2 (kPa) 
Respiratory 
0 ≥400 ≥53.4 
1 300-399 40-53.33 
2 200-299 26.7-39.9 
3 100-199 and Respiratory support 13.3-26.6 and Respiratory support 
4 <100 and Respiratory Support <13.3 and Respiratory support 
  Brazil England 
 Points Definition by: MAP or vasoactive drugs* 
Definition by: Use of advanced 
cardiovascular support# 
Cardiovascular 
0 Without drugs or hypotension  
1 MAP < 70 mmHg  
2 Dopamine ≤5 or Dobutamine (any dose) X 
3 Dopamine >5 or Epinephrine ≤0.1 or Norepinephrine ≤0.1 X 
4 Dopamine >15 or Epinephrine >0.1 or Norepinephrine >0.1 X 
*Vasoactive drugs administrated at least for one hour. In µg/kg-min 
  Brazil England 
 Points Definition by: Platelets count (x109/L) Definition by: Platelets count (x109/L) 
Haematological 
0 ≥150 ≥150 
1 100-149 100-149 
2 50-99 50-99 
3 20-49 20-49 
4 <20 <20 
  Brazil England 
 Points Definition by: Creatinine (mg/dL) or Urinary Output (mL) 
Definition by: Creatinine (µmol/L) or 
Urinary Output (mL) 
Renal 
0 sCr <1.2 sCr <110 
1 sCr 1.2-1.9 sCr 110-170 
2 sCr 2.0-3.4 sCr 171-299 
3 sCr 3.5-4.9 or UO<500 ml/24h sCr 300-440 or UO<500 ml/24h 
4 sCr ≥5.0 or UO≤ 200ml/24h sCr >440 or UO≤ 200ml/24h 
  Brazil England 
 Points Definition by: Glasgow Coma Scale 
Definition 
by: 
Glasgow 
Coma 
Scale 
Or Sedated/paralyzed 
Neurological 
0 15 15  
1 13-14 13-14  
2 10-12 10-12 X 
3 6-9 6-9 X 
4        <6      <6  X 
For those sedated/mechanically ventilated, the GCS calculated was the GCS immediately before sedation/intubation 
Note: Hepatic organ dysfunction was not available in both cohorts. 
 
# Advanced cardiovascular support is used as part of the critical care minimum dataset collection in ICUs in England. Advanced 
cardiovascular support is indicated by one or more of the following: Multiple intravenous vasoactive and/or rhythm controlling drugs 
when used simultaneously to support or control arterial pressure, cardiac output or organ / tissue perfusion, (e.g. inotropes, 
amiodarone, nitrates); Continuous observation of cardiac output and derived indices (e.g. pulmonary artery catheter, lithium dilution, 
pulse contour analyses, oesophageal Doppler, impedance and conductance methods); Intra-aortic balloon pumping and other 
assist devices and/or Insertion of a temporary cardiac pacemaker (criteria valid for each day of therapeutic connection to a 
functioning external pacemaker unit). Importantly, to qualify for advanced support status, at least one drug needs to be vasoactive. 
In our cohort 98% of patients had vasoactive drugs meeting the cardiovascular SOFA criteria. 
eTable3: Site of infection definition in Brazil and England 
 
 
 Brazil England 
Database ORCHESTRA study / Epimed system ICNARC 
Coding 
The site of infection was 
determined clinically at the 
moment of ICU admission, 
following hierarchical codes(1). 
The hierarchy starts by 
classifying the admission as (a) 
medical, elective surgery or 
emergency/urgent surgery. 
Based on the initial 
classification, a list of (b) main 
reasons for admission is 
available, comprising several 
categories, including infection. 
Within each main category (e.g. 
infection), (c) there is a list of 
pre-specified diagnoses which 
for infection refers to sites of 
infection (e.g., pneumonia, 
meningitis, etc). 
Diagnostic data are determined 
clinically at admission and coded 
using the hierarchical ICNARC 
Coding Method(2). The hierarchy has 
5 tiers: (a) surgical status (coded as 
surgical versus non-surgical); (b) 
organ system (coded as respiratory, 
cardiovascular, neurological, 
genitourinary, endocrine/metabolic, 
haematological, musculoskeletal, 
dermatologic); (c) anatomical site 
(such as lung, bronchi for respiratory 
system); (d) process leading to 
admission (such as infection, trauma) 
and (e) clinical condition (such as 
bacterial pneumonia). A code is 
automatically generated that 
represents a patient’s clinical 
diagnosis route through this 
hierarchy. All patients registered in 
ICNARC database participating ICU’s 
are mandated to provide at least one 
coded reason for each hierarchy. 
 
  
 
eFigure1. Study flowchart for the Brazil and England cohorts 
 
 
 
 
 
 
 
 
 
  
58,316 first adult medical
patients from 164 general ICUs
Period Jan 2013-Dez 2013
19,491 medical
patients + infection
Excluding 38,825 patients without infection as main 
admission diagnosis (66.6%)
17,921 medical patients + 
infection + at least one organ 
failure (sepsis)
Excluding patients without organ failure at 
diagnosis 1,570 (8.1%)
34,150 first adult medical
patients from 62 general ICUs
Period Jan 2013-Dez 2013
10,167 medical
patients + infection
Excluding 23,983 patients without infection as main 
admission diagnosis (70.2%)
4,505 medical patients + 
infection + at least one organ 
failure (sepsis)
Excluding patients without organ failure at 
diagnosis 5,662 (55.7%)
BRAZIL
88 general and specialized ICUs
Period Jan 2013-Dez 2013
Excluding 10 Units 
2 units with less than 12 months of data collection
8 units with more than 10% of missing on core data
Excluding 16 Specialized Units 
ENGLAND
164 general ICUs
Period Jan 2013-Dez 2013
Excluding 0 Specialized Units 
Excluding 0 Units 
0 units with less than 12 months of data collection
0 units with more than 10% of missing on core data
eTable4: Sepsis-specific patient characteristics and length of stay stratified by ICU and 
hospital mortality. 
 
 England (n=17,921) Brazil (n=4,505) 
Sepsis-specific patient characteristics   
Number of organ dysfunctions within first 24h   
Median number (IQR) 2 (1-3) 1 (1-2) 
1 5881 (32.8%) 2474 (54.9%) 
2 5852 (32.6%) 1205 (26.8%) 
3 3935 (22.0%) 577 (12.8%) 
4 1856 (10.4%) 220 (4.9%) 
5 397 (2.2%) 29 (0.6%) 
Type of organ dysfunction and combinations1   
Respiratory (only) 4317 (24.1%) 449 (10.0%) 
Cardiovascular (only) 185 (1.0%) 419 (9.3%) 
Renal (only) 749 (4.2%) 598 (13.3%) 
Hematological (only) 281 (1.6%) 356 (7.9%) 
Neurological (only) 349 (2.0%) 652 (14.5%) 
Respiratory + Cardiovascular 1089 (6.1%) 294 (6.5%) 
Respiratory + Neurological 1686 (9.4%) 200 (4.4%) 
Cardiovascular + Renal 217 (1.2%) 157 (3.5%) 
Respiratory + Cardiovascular + Neurological 998 (5.6%) 210 (4.7%) 
Respiratory + Cardiovascular + Renal 989 (5.5%) 153 (3.4%) 
Respiratory + Cardiovascular + Renal + Neurological 991 (5.5%) 123 (2.7%) 
ICU mortality 5496 (30.7%) 1431 (31.8%) 
ICU Length of stay, days   
Overall   
Mean (SD) 8.2 (10) 10.5 (13) 
Median (IQR) 5 (3-10) 6 (4-12) 
ICU survivors   
Mean (SD) 9.1 (11) 9.8 (11) 
Median (IQR) 6 (3-10) 6 (4-11) 
ICU non-survivors   
Mean (SD) 6.3 (9) 12.1 (16) 
Median (IQR) 3 (2-8) 7 (3-15) 
Hospital mortality 7045 (39.3%) 1867 (41.4%) 
Hospital Length of stay, days   
Overall   
Mean (SD) 23.6 (30) 26.8 (38) 
Median (IQR) 15 (8-29) 16 (8-31) 
ICU survivors   
Mean (SD) 29.1 (33) 26.2 (33) 
Median (IQR) 19 (11-36) 16 (9-30) 
ICU non-survivors   
Mean (SD) 15.2 (20) 27.7 (44) 
Median (IQR) 9 (3-19) 15 (6-32) 
1Organ dysfunction combinations with at least 100 occurrences in both datasets in the first 24 hours 
following ICU admission (Totals were 11,851 (66%) patients from England and 3,611 (80%) patients from 
Brazil)
eTable 5: Adjusted multilevel logistic regression models for the country effect (Brazil versus England) on sepsis hospital mortality (sensitivity analysis) 
 
Model Exposure OR (95% CI) P value AUROC Brier score 
Main analysis      
All patients (n=22061)      
Model 1 – Baseline model Brazil/England 1.12 (0.98-1.30) 0.105 0.608 (0.600-0.615) 0.2303 
Model 2 – Adjusted for general characteristics1 Brazil/England 0.88 (0.75-1.02) 0.089 0.712 (0.705-0.719) 0.2082 
Model 3A – Adjusted for general + sepsis-specific characteristics 
(site of infection and type of organ dysfunction)2 Brazil/England 1.22 (1.05-1.43) 0.010 0.784 (0.778-0.790) 0.1838 
Model 3B – Adjusted for general + sepsis-specific characteristics 
(site of infection and number of organ dysfunction)3 Brazil/England 1.40 (1.22-1.62) <0.001 0.777 (0.771-0.783) 0.1864 
      
Sensivity analysis      
      
Without chronic comorbidities (n=17368)      
Model 1 – Baseline model Brazil/England 1.01 (0.87-1.18) 0.853 0.602 (0.595-0.610) 0.2326 
Model 4 – Adjusted for general characteristics4 Brazil/England 0.77 (0.65-0.91) 0.002 0.711 (0.704-0.719) 0.2022 
Model 5A – Adjusted for general + sepsis-specific characteristics 
(site of infection and type of organ dysfunction)5 Brazil/England 1.11 (0.93-1.32) 0.239 0.788 (0.781-0.795) 0.1773 
Model 5B – Adjusted for general + sepsis-specific characteristics 
(site of infection and number of organ dysfunction)6 Brazil/England 1.29 (1.10-1.51) 0.002 0.780 (0.773-0.787) 0.1801 
With immunocompromised comorbities not grouped (n=22061)      
Model 1 – Baseline model Brazil/England 1.12 (0.98-1.30) 0.105 0.608 (0.600-0.615) 0.2303 
Model 6 – Adjusted for general characteristics7 Brazil/England 0.84 (0.73-0.98) 0.029 0.714 (0.707-0.721) 0.2077 
Model 7A – Adjusted for general + sepsis-specific characteristics 
(site of infection and type of organ dysfunction)8 Brazil/England 1.18 (1.01-1.37) 0.037 0.785 (0.779-0.791) 0.1834 
Model 7B – Adjusted for general + sepsis-specific characteristics 
(site of infection and number of organ dysfunction)9 Brazil/England 1.35 (1.17-1.56) <0.001 0.778 (0.772-0.784) 0.1859 
1 Adjusted for age (restricted cubic spline), sex, cardiovascular, respiratory, renal, hepatic comorbidities, immunocompromised, functional status and, admission source and time from 
hospitalization to ICU admission (restricted cubic spline) 
2 Adjusted for characteristics in model 2 + site of infection and type of organ dysfunction and first-order interaction between each organ dysfunction system 
3 Adjusted for characteristics in model 2 + site of infection and number of organ dysfunctions (Number of organ failures entered as factors) 
4 Adjusted for age (restricted cubic spline), sex, functional status and, admission source and time from hospitalization to ICU admission (restricted cubic spline) 
5 Adjusted for characteristics in model 4 + site of infection and type of organ dysfunction and first-order interaction between each organ dysfunction system 
6 Adjusted for characteristics in model 4 + site of infection and number of organ dysfunctions (Number of organ failures entered as factors) 
7 Adjusted for age (restricted cubic spline), sex, cardiovascular, respiratory, renal, hepatic comorbidities, haematological malignancy, AIDS, metastatic disease (solid neoplasia), steroid 
use, functional status and, admission source and time from hospitalization to ICU admission (restricted cubic spline) 
8 Adjusted for characteristics in model 6 + site of infection and type of organ dysfunction and first-order interaction between each organ dysfunction system 
9 Adjusted for characteristics in model 6 + site of infection and number of organ dysfunctions (Number of organ failures entered as factors) 
 
eFigure2: Effect modification of country effect on hospital mortality and by pre-specified 
subgroups and deciles of the predicted risk from the Model 3-B 
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.006
<0.001
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P value
Higher Odds for England  Higher Odds for Brazil
.5 1 2 4 8
eTable6: Effect modification of country effect on hospital mortality and by pre-specified 
subgroups in the Model 3-A 
Stratified by Country Events/ subtotal (%) Stratum-specific adjusted OR (95%CI) 
P value for 
interaction 
Source of Admission     
Emergency department 
England 2038/5874 (34.7%) 1 (Reference) 
0.176 
Brazil 1099/3098 (35.5%) 1.17 (0.99-1.38) 
Not emergency department 
England 4966/11963 (41.5%) 1 (Reference) 
Brazil 647/1126 (57.5%) 1.34 (1.09-1.63) 
Time from hospitalization to ICU admission    
<1 day England 2451/7195 (34.1%) 1 (Reference) 
0.003 
 Brazil 833/2568 (32.4%) 1.16 (0.98-1.37) 
1-2 days England 2021/5407 (37.4%) 1 (Reference) 
 Brazil 318/754 (42.2%) 1.23 (0.98-1.55) 
3-7 days England 1318/3032 (43.5%) 1 (Reference) 
 Brazil 241/362 (66.6%) 1.96 (1.46-2.64) 
≥8 days England 1214/2203 (55.1%) 1 (Reference) 
 Brazil 354/540 (65.6%) 1.07 (0.82-1.40) 
Site of infection     
Respiratory England 4457/11025 (40.4%) 1 (Reference) 
<0.001 
 Brazil 956/2172 (44.0%) 0.98 (0.83-1.16) 
Genitourinary England 191/863 (22.1%) 1 (Reference) 
 Brazil 204/710 (28.7%) 1.76 (1.32-2.36) 
Gastrointestinal England 878/2290 (38.3%) 1 (Reference) 
 Brazil 121/273 (44.3%) 1.89 (1.36-2.61) 
Musculoskeletal/Dermatological England 259/738 (35.1%) 1 (Reference) 
 Brazil 81/241 (33.6%) 1.64 (1.11-2.43) 
Neurological England 77/444 (17.3%) 1 (Reference) 
 Brazil 17/40 (42.5%) 3.18 (1.46-6.94) 
Cardiovascular England 147/347 (42.4%) 1 (Reference) 
 Brazil 40/91 (44.0%) 1.02 (0.57-1.82) 
Unknown England 995/2130 (46.7%) 1 (Reference) 
 Brazil 327/697 (46.9%) 1.42 (1.12-1.82) 
[Abbreviations: n=number; % –percentage; 95% CI: 95% Confidence intervals] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
eTable7: Effect modification of country effect on hospital mortality and by pre-specified 
subgroups for hospital mortality in the Model 3-B 
Stratified by Country No. events/subtotal (%) Stratum-specific adjusted OR (95% CI) 
P value for 
interaction 
Source of Admission     
Emergency department 
England 2038/5874 (34.7%) 1 (Reference) 
0.247 
Brazil 1099/3098 (35.5%) 1.34 (1.14-1.57) 
Not emergency department 
England 4966/11963 (41.5%) 1 (Reference) 
Brazil 647/1126 (57.5%) 1.49 (1.24-1.80) 
Time from hospitalization to ICU admission    
<1 day England 2451/7195 (34.1%) 1 (Reference) 
0.005 
 Brazil 833/2568 (32.4%) 1.33 (1.13-1.57) 
1-2 days England 2021/5407 (37.4%) 1 (Reference) 
 Brazil 318/754 (42.2%) 1.43 (1.14-1.78) 
3-7 days England 1318/3032 (43.5%) 1 (Reference) 
 Brazil 241/362 (66.6%) 2.22 (1.66-2.96) 
≥8 days England 1214/2203 (55.1%) 1 (Reference) 
 Brazil 354/540 (65.6%) 1.29 (1.00-1.67) 
Site of infection     
Respiratory England 4457/11025 (40.4%) 1 (Reference) 
<0.001 
 Brazil 956/2172 (44.0%) 1.14 (0.97-1.34) 
Genitourinary England 191/863 (22.1%) 1 (Reference) 
 Brazil 204/710 (28.7%) 2.04 (1.53-2.72) 
Gastrointestinal England 878/2290 (38.3%) 1 (Reference) 
 Brazil 121/273 (44.3%) 2.21 (1.61-3.03) 
Musculoskeletal/Dermatological England 259/738 (35.1%) 1 (Reference) 
 Brazil 81/241 (33.6%) 1.69 (1.16-2.47) 
Neurological England 77/444 (17.3%) 1 (Reference) 
 Brazil 17/40 (42.5%) 3.54 (1.62-7.73) 
Cardiovascular England 147/347 (42.4%) 1 (Reference) 
 Brazil 40/91 (44.0%) 1.12 (0.64-1.98) 
Unknown England 995/2130 (46.7%) 1 (Reference) 
 Brazil 327/697 (46.9%) 1.67 (1.32-2.12) 
Number of organ dysfunctions     
1 England 1373/5855 (23.5%) 1 (Reference) 
<0.001 
 Brazil 597/2333 (25.6%) 1.13 (0.95-1.34) 
2 England 2080/5830 (35.7%) 1 (Reference) 
 Brazil 577/1116 (51.7%) 1.65 (1.37-1.98) 
3 England 2001/3911 (51.2%) 1 (Reference) 
 Brazil 377/545 (69.2%) 1.70 (1.33-2.17) 
4 England 1247/1846 (67.6%) 1 (Reference) 
 Brazil 171/202 (84.7%) 2.17 (1.39-3.37) 
5 England 303/395 (76.7%) 1 (Reference) 
 Brazil 24/28 (85.7%) 1.72 (0.53-5.56) 
 [Abbreviations: n=number; % –percentage; 95% CI: 95% Confidence intervals] 
eTable8: Effect modification of country effect on hospital mortality and by deciles of the 
predicted risk from the Model 3-A 
 
Stratified by Country No. events/ subtotal 
Stratum-specific 
adjusted OR (95% CI) 
P value for 
interaction 
Deciles risk     
1.9-11.3% 
England 87/1667 (5.2%) 1 (Reference) 
0.031 
Brazil 49/538 (9.1%) 1.82 (1.26-2.62) 
11.3-17.6% 
England 215/1808 (11.9%) 1 (Reference) 
Brazil 68/399 (17.0%) 1.52 (1.13-2.05) 
17.6-23.5% 
England 374/1825 (20.5%) 1 (Reference) 
Brazil 97/381 (25.5%) 1.33 (1.03-1.71) 
23.5-29.6% 
England 508/1816 (28.0%) 1 (Reference) 
Brazil 115/390 (29.5%) 1.08 (0.85-1.37) 
29.6-36.7% 
England 646/1790 (36.1%) 1 (Reference) 
Brazil 155/415 (37.4%) 1.06 (0.85-1.32) 
36.7-44.0% 
England 739/1815 (40.7%) 1 (Reference) 
Brazil 162/392 (41.3%) 1.03 (0.82-1.28) 
40.0-52.2% 
England 883/1783 (49.5%) 1 (Reference) 
Brazil 206/423 (48.7%) 0.97 (0.78-1.20) 
52.2-61.8% 
England 1032/1815 (56.9%) 1 (Reference) 
Brazil 217/391 (55.5%) 0.95 (0.76-1.18) 
61.8-73.3% 
England 1176/1822 (64.5%) 1 (Reference) 
Brazil 266/384 (67.3%) 1.24 (0.98-1.57) 
73.3-98.2% 
England 1344/1696 (79.3%) 1 (Reference) 
Brazil 411/511 (80.4%) 1.08 (0.84-1.38) 
[Abbreviations: n=number; % –percentage; 95% CI: 95% Confidence intervals] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
eTable9: Effect modification of country effect on hospital mortality and by deciles of the 
predicted risk from the Model 3-B 
 
 
Stratified by Country No. events/ subtotal 
Stratum-specific 
adjusted OR (95% CI) 
P value for 
interaction 
Deciles risk     
2.5-12.1% 
England 88/1618 (5.4%) 1 (Reference) 
0.006 
Brazil 56/587 (9.5%) 1.83 (1.29-2.60) 
12.1-18.4% 
England 210/1753 (12.0%) 1 (Reference) 
Brazil 84/453 (18.5%) 1.67 (1.27-2.21) 
18.4-24.5% 
England 387/1789 (21.6%) 1 (Reference) 
Brazil 132/418 (31.6%) 1.67 (1.32-2.12) 
24.5-30.6% 
England 486/1778 (27.3%) 1 (Reference) 
Brazil 139/428 (32.5%) 1.28 (1.02-1.61) 
30.6-37.1% 
England 621/1788 (34.7%) 1 (Reference) 
Brazil 165/418 (39.5%) 1.23 (0.99-1.53) 
37.1-43.9% 
England 745/1809 (41.2%) 1 (Reference) 
Brazil 163/395 (41.3%) 1.00 (0.80-1.25) 
43.9-51.8% 
England 871/1825 (47.7%) 1 (Reference) 
Brazil 197/383 (51.4%) 1.16 (0.93-1.45) 
51.8-61.0% 
England 1043/1842 (56.6%) 1 (Reference) 
Brazil 210/364 (57.7%) 1.05 (0.83-1.31) 
61.0-72.2% 
England 1178/1858 (63.4%) 1 (Reference) 
Brazil 238/348 (68.4%) 1.25 (0.98-1.60) 
72.2-97.8% 
England 1375/1777 (77.4%) 1 (Reference) 
Brazil 362/430 (84.2%) 1.56 (1.17-2.06) 
 [Abbreviations: n=number; % –percentage; 95% CI: 95% Confidence intervals] 
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